PT Kalbe Farma Tbk - Company Profile

Powered by

All the sales intelligence you need on PT Kalbe Farma Tbk in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how PT Kalbe Farma Tbk fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with PT Kalbe Farma Tbk.

Back to companies

PT Kalbe Farma Tbk: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on PT Kalbe Farma Tbk patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
MY164917A Grant Lactate containing pharmaceutical composition and uses thereof February 15, 2018
TWI377937B Grant Non-essential amino acids containing pharmaceutical composition and uses thereof A61K31/198; A61K31/401; A61K31/405; A61K31/4172; A61K9/0012 December 01, 2012
CN100777416B Grant Lactate containing pharmaceutical composition and uses thereof A23L33/16; A23V2002/00; A61K31/19; A61K33/00; A61K33/06; A61P1/16; A61P11/00; A61P13/12; A61P25/00; A61P25/28; A61P3/00; A61P3/04; A61P3/08; A61P3/10; A61P31/04; A61P41/00; A61P43/00; A61P7/00; A61P7/08; A61P7/10; A61P9/00; A61P9/04; A61P9/10; A61P9/12 November 07, 2012
IL171721A Application Use of a composition containing l-lactic acid or lactate and potassium for the manufacture of a pharmaceutical composition for the treatment of brain edema wherein the brain edema is caused by traumatic or non-traumatic brain injury A23L33/16; A23V2002/00; A61K31/19; A61K33/00; A61K33/06; A61P1/16; A61P11/00; A61P13/12; A61P25/00; A61P25/28; A61P3/00; A61P3/04; A61P3/08; A61P3/10; A61P31/04; A61P41/00; A61P43/00; A61P7/00; A61P7/08; A61P7/10; A61P9/00; A61P9/04; A61P9/10; A61P9/12 May 31, 2012
CA2523740C Grant Lactate containing pharmaceutical composition and uses thereof A23L33/16; A23V2002/00; A61K31/19; A61K33/00; A61K33/06; A61P1/16; A61P11/00; A61P13/12; A61P25/00; A61P25/28; A61P3/00; A61P3/04; A61P3/08; A61P3/10; A61P31/04; A61P41/00; A61P43/00; A61P7/00; A61P7/08; A61P7/10; A61P9/00; A61P9/04; A61P9/10; A61P9/12 May 15, 2012
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer